CFD
LUCD icon

Creative Financial Designs’s Lucid Diagnostics LUCD Stock Holding History

Creative Financial Designs’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,000
Closed -$17.3K – 2310
2026
Q1 		$17.3K Hold
15,000
– – ﹤0.01% 1241
2025
Q4 		$16.4K Hold
15,000
– – ﹤0.01% 1210
2025
Q3 		$15.2K Buy
15,000
+6,500
+76% +$7.1K ﹤0.01% 1232
2025
Q2 		$9.78K Buy
+8,500
New +$11K ﹤0.01% 1352

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Creative Financial Designs's LUCD Position: Q2 2026 in Review

Creative Financial Designs sold out of Lucid Diagnostics (LUCD) in Q2 2026, closing a stake of 15,000 shares — an estimated $17.3K sold.

Creative Financial Designs first reported a position in LUCD in Q2 2025 and held it in 4 quarters. The position peaked at $17.3K in Q1 2026. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Creative Financial Designs reported no remaining Lucid Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Creative Financial Designs sold 15,000 Lucid Diagnostics shares in Q2 2026, an estimated $17.3K.
  • Creative Financial Designs first reported a position in Lucid Diagnostics in Q2 2025 and held it in 4 quarters.
  • Creative Financial Designs's Lucid Diagnostics position peaked at $17.3K in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.